Machine learning enriched MthUPO variants for beta-damascone hydroxylation
Researchers combined experimental activity measurements with machine learning to enrich a second MthUPO peroxygenase library for substrate-specific activity. Across 506 distinct variants screened and sequenced, 97 of 108 variants in the ML-enriched library outperformed wild type in the screening assay, compared with 14% in the initial htFuncLib library. The authors report an 11.8-fold turnover number for the best variant producing 4-hydroxy-beta-damascone, with greater than 99% regioisomeric excess. Separate 5–12-fold enrichment and recovery figures in the paper are simulation benchmarks and are not treated as experimental outcomes.
Technology: Machine-learning enrichment of experimental enzyme-activity data following htFuncLib design
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Preprint
- Test type: direct test
- Tested: The preprint reports screening and sequencing 506 distinct MthUPO variants. In the ML-enriched library, 97 of 108 variants outperformed wild type in the screening assay, compared with 14% in the initial htFuncLib library. The best reported variant had an 11.8-fold turnover number for 4-hydroxy-beta-damascone with greater than 99% regioisomeric excess.
- Still unknown: The preprint is not peer reviewed. The paper separately reports simulation-only MLEE/htFuncLib comparisons, which are excluded from the experimental result summary. Assay outcomes do not establish process-scale productivity or commercial suitability.
- AI role: Machine learning used experimental enzyme-activity measurements to enrich a library of MthUPO variants for testing, following an earlier htFuncLib design stage.
Evidence sources: https://api.biorxiv.org/details/biorxiv/10.64898/2026.07.20.739108 · https://www.biorxiv.org/content/10.64898/2026.07.20.739108v1.full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 17 Nov 2026. Review scope: Official bioRxiv API v1 metadata/abstract and primary indexed v1 full-text excerpts; simulation and experimental results kept separate..
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.